Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

Clinical trial NCT06369272 · COMPLETED

Trial details

NCT number: NCT06369272
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Maternal Outcomes Infant Outcomes Pregnancy

Start date: 2023-03-01
Primary completion: 2023-10-20
Enrollment: 1192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.